Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism and thrombophilia: A pooled analysis of RE-COVER™ and RE-COVER™ II

Pas encore traduit Pas encore traduit

Cet article est inclus dans 2 Systematic reviews Systematic reviews (2 references)

This article is part of the following publication threads:
  • RE-COVER I [Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism] (15 documents)
  • RE-COVER II [Phase III Study Testing Efficacy and Safety of Oral Dabigatran Etexilate versus Warfarin for 6 Month Treatment for Acute Symptomatic Venous Thromboembolism (VTE)] (12 documents)
This article is part of the following matrixes of evidence:
Loading references information
Cet article n'a pas de résumé
Epistemonikos ID: 02f1a01358c88d2fb6dc259cc267fbb21d3093bc
First added on: May 17, 2016